Fennec制药(FENC)
9.09 0.00 0.0%
| 今开：0.0 | 昨收：9.09 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.46338164E8 |
Fennec制药的热门讨论
SeekingBiotech03-19 00:30
$Fennec制药(FENC)$
FENC announced an exclusive licensing agreement under which Norgine will commercialize PEDMARQSI in Europe, Australia, and New Zealand. PEDMARQSI is an approved therapy in the EU and U.K. for the prevention of ototoxicity (hearing loss) induced by cispl...查看全文
证券出售报告
Fennec制药(FENC)04-06 04:25
$Fennec制药(FENC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002966 Act: 33 Size: 8 KB 网页链接查看全文
持股变动声明
Fennec制药(FENC)03-28 04:35
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009205 Size: 8 KB 网页链接查看全文
年度财报
Fennec制药(FENC)03-30 04:25
$Fennec制药(FENC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-004383 Act: 34 Size: 10 MB 网页链接查看全文
持股变动声明
Fennec制药(FENC)04-04 05:05
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010047 Size: 5 KB 网页链接查看全文
持股变动声明
Fennec制药(FENC)03-26 07:35
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009068 Size: 5 KB 网页链接查看全文
证券出售报告
Fennec制药(FENC)04-18 04:25
$Fennec制药(FENC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003124 Act: 33 Size: 6 KB 网页链接查看全文
证券出售报告
Fennec制药(FENC)04-20 04:15
$Fennec制药(FENC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003137 Act: 33 Size: 7 KB 网页链接查看全文
证券出售报告
Fennec制药(FENC)04-23 04:25
$Fennec制药(FENC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003158 Act: 33 Size: 8 KB 网页链接查看全文
持股变动声明
Fennec制药(FENC)04-04 05:05
$Fennec制药(FENC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010059 Size: 5 KB 网页链接查看全文
Fennec制药的最新讨论
SeekingBiotech03-19 00:30
$Fennec制药(FENC)$
FENC announced an exclusive licensing agreement under which Norgine will commercialize PEDMARQSI in Europe, Australia, and New Zealand. PEDMARQSI is an approved therapy in the EU and U.K. for the prevention of ototoxicity (hearing loss) induced by cispl...查看全文
薛定锷之猫2023-02-01 00:20
$Fennec制药(FENC)$ 会有公司收购它吗？If yes，收购价会是多少呢？
Part I:
1、 PEDMARK® is the First and Only FDA-Approved Therapy Indicated to Reduce the Risk of Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic Solid ...查看全文
美股律师郝俊波2022-02-11 15:14
$Fennec制药(FENC)$ 【Fennec制药(FENC)最新证券集体诉讼】
Fennec Pharmaceuticals Inc(FENC)因证券欺诈案已经于近日被投资者集体诉讼至法院。在目前的诉讼中投资者指控该公司在2021年5月28日至 2021年11月26日期间（即本案集体诉讼期间）进行虚假陈述，违反证券法，令投资者受损。
Fenn...查看全文
chuminhua2021-11-30 10:47
11月29日，Fennec Pharmaceuticals 的股价周一下跌多达 48%，此前该公司表示预计将收到另一封针对其化疗引起的听力损失预防药物的完整回复函 (CRL)。 Fennec 正在寻求批准其名为 Pedmark 的硫代硫酸钠静脉制剂，以防止 1 个月至 18 岁的局部非转移性实体瘤患者与顺铂化疗相关的耳毒性。
根据 F...查看全文
美股律师郝俊波2020-08-18 11:29
$Fennec制药(FENC)$ 2020年8月11日Fennec Pharmaceuticals Inc(NASDAQ: FENC)发布消息称收到美国药监局关于该公司正在申请上市的PEDMARK产品的调查函。该函中称药监局在对该产品评估后认为存在需要解决的问题。受此不利消息影响，该公司股价大跌34%令投资者受损。
我们律师在此提醒投资者注意...查看全文
![[吐血]](http://js.xueqiu.com/ugc/images/face/emoji_23_blood.png?v=1 "[吐血]"){kind=small}
![[加油]](http://js.xueqiu.com/ugc/images/face/emoji_05_struggle.png?v=1 "[加油]"){kind=small}
Fennec制药的公告
$Fennec制药(FENC)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-15 AccNo: 0001144204-19-014220 Size: 7 MB 网页链接
$Fennec制药(FENC)$ 8-K - Current report Filed: 2019-03-14 AccNo: 0001144204-19-013797 Size: 84 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Fennec制药(FENC)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001013594-19-000162 Size: 94 KB 网页链接
$Fennec制药(FENC)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001493152-19-002115 Size: 176 KB 网页链接
$Fennec制药(FENC)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0000902664-19-001013 Size: 58 KB 网页链接
$Fennec制药(FENC)$ 8-K - Current report Filed: 2019-02-04 AccNo: 0001144204-19-004627 Size: 304 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Fennec Pharmaceuticals Inc.(FENC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-13 AccNo: 0001144204-18-059235 Size: 4 MB 网页链接
$Fennec Pharmaceuticals Inc.(FENC)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-09-10 AccNo: 0000919574-18-006066 Size: 148 KB 网页链接
$Fennec Pharmaceuticals Inc.(FENC)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-08-17 AccNo: 0000919574-18-005749 Size: 158 KB 网页链接
$Fennec Pharmaceuticals Inc.(FENC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-13 AccNo: 0001144204-18-043914 Size: 4 MB 网页链接